US FDA Extends License of the GVK BIO Biomarker Database
02:00 EST 4 Feb 2013 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
GVK
Biosciences (GVK BIO) today announced that it is extending its
Clinical Biomarker Database (GOBIOM) license to the Biomarker
Qualification Group of the US Food and Drug Administration (US FDA). The
GOBIOM database, wh...
Other Sources for this Article
GVK Biosciences Private Limited
Sreeni Devidas
Vice President
– Business Development
T 443-838-6260
E sreeni.devidas@gvkbio.com
W
www.gvkbio.com
or
Sushant
Datta
DGM – Corporate Brand & Communications
T 0091 40
66929999
E sushant.datta@gvkbio.com
W
www.gvkbio.com
More From BioPortfolio on "US FDA Extends License of the GVK BIO Biomarker Database"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
